Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users (Q36065237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

main subject

anti-retroviral agent

0 references

HIV

0 references

HIV type 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

intravenous substance abuse

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

highly active antiretroviral therapy

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

15 March 2024

7

Robert S Hogg

1 reference

12 August 2017

1

Evan Wood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

2

Julio S G Montaner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

4

Mark W Tyndall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

5

Martin T Schechter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

3

Benita Yip

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Julio S. G. Montaner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

15 March 2024

Michael V. O'Shaughnessy

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

15 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

30 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14517122

full work available at URL

15 March 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14517122/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

http://www.cmaj.ca/cgi/content/abstract/169/7/656

15 March 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

http://www.cmaj.ca/cgi/content/full/169/7/656

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

http://www.cmaj.ca/cgi/reprint/169/7/656.pdf

15 March 2024

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14517122/pdf/?tool=EBI

15 March 2024

file format

Portable Document Format

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

https://europepmc.org/articles/PMC202281

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

https://europepmc.org/articles/PMC202281?pdf=render

15 March 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517122

Canadian Medical Association Journal

15 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

656-661

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?

19 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Antiretroviral medication use among injection drug users: two potential futures

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Needle exchange is not enough: lessons from the Vancouver injecting drug use study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

The assessment of refill compliance using pharmacy records: methods, validity, and applications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Intersecting epidemics--crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Interim proposal for a WHO Staging System for HIV infection and Disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Self-reported antiretroviral therapy in injection drug users.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Helping the urban poor stay with antiretroviral HIV drug therapy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Barriers to use of free antiretroviral therapy in injection drug users.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Scope of the AIDS epidemic in the United States

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=202281

Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease

5 December 2018

1 reference

12 December 2020

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

12 December 2020

Adherence to triple therapy and viral load response

1 reference

12 December 2020

Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use

1 reference

12 December 2020

HIV in the United States at the turn of the century: an epidemic in transition

1 reference

12 December 2020

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load

1 reference

12 December 2020

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

12 December 2020

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14517122%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference